Recommendation ID
NG136/05
Question

Relaxation therapies: What is the clinical and cost effectiveness of relaxation therapies for managing primary hypertension in adults in terms of reducing cardiovascular events and improving quality of life?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale on relaxation therapies.

Full details of the evidence and the committee's discussion are in evidence review H: relaxation therapies.


Source guidance details

Comes from guidance
Hypertension in adults: diagnosis and management
Number
NG136
Date issued
August 2019

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/03/2022